Legislation: batch A — AK AL AR AZ CO CT DE GA HI IA ID

Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>

legislation/us/states/de/151/hb-399.md

@@ -0,0 +1,85 @@
+---
+type: "Bill"
+title: "AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PRACTICE OF PHARMACY."
+description: "All human laboratory testing is regulated under the Clinical Laboratory Improvement Amendments of 1988 (“CLIA”). CLIA-waived tests are simple laboratory examinations and procedures that have an insignificant risk of an erroneous result. Common CLIA-waived tests include Influenza, HIV, COVID-19, and lipid-panel tests. Amid COVID-19 pandemic, the need for immediate diagnostic services that are close to home became vital. This bill authorizes pharmacists to order and perform tests authorized by the FDA and CLIA-waived and provide treatment for such health conditions."
+jurisdiction: "us/states/de"
+legislature: "Delaware General Assembly"
+session: "151"
+identifier: "HB 399"
+citation: "Delaware HB 399 (151)"
+classification: ["bill"]
+subjects: []
+status: "enacted"
+primary_sponsors: ["Andria L. Bennett", "Kendra Johnson", "Marie Pinkney"]
+version_count: 4
+action_count: 16
+vote_count: 3
+first_action: "2022-05-03"
+last_action: "2022-10-03"
+source: "openstates"
+source_identifier: "ocd-bill/614f4e60-ae0f-42de-9e2e-a9a0e61e4bd0"
+source_url: "https://legis.delaware.gov/BillDetail?LegislationId=109428"
+source_hash: "2db59daa6dca240f12c542529a65c49ec0b08fa67dfd58a30b14e5b8c176bf1c"
+vintage: "2026-07-01"
+source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
+retrieved_at: "2026-07-06"
+confidence: "reported"
+tags: ["legislation", "bill", "us-de"]
+---
+
+# Delaware HB 399 (151) — AN ACT TO AMEND TITLE 24 OF THE DELAWARE CODE RELATING TO PRACTICE OF PHARMACY.
+
+All human laboratory testing is regulated under the Clinical Laboratory Improvement Amendments of 1988 (“CLIA”). CLIA-waived tests are simple laboratory examinations and procedures that have an insignificant risk of an erroneous result. Common CLIA-waived tests include Influenza, HIV, COVID-19, and lipid-panel tests. Amid COVID-19 pandemic, the need for immediate diagnostic services that are close to home became vital. This bill authorizes pharmacists to order and perform tests authorized by the FDA and CLIA-waived and provide treatment for such health conditions.
+
+## Version chain
+
+The bill's text revisions, in order — the diff chain from filing to enrollment.
+
+1. **Bill Text** (committee substitute) — [source](https://legis.delaware.gov/json/BillDetail/GenerateHtmlDocument?legislationId=109428&legislationTypeId=1&docTypeId=2&legislationName=HB399)
+2. **HA 1 to HB 399** (committee substitute) — [source](http://legis.delaware.gov/json/BillDetail/GeneratePdfDocument?legislationId=109532&legislationTypeId=5&docTypeId=2)
+3. **HA 2 to HB 399** (committee substitute) — [source](http://legis.delaware.gov/json/BillDetail/GeneratePdfDocument?legislationId=109553&legislationTypeId=5&docTypeId=2)
+4. **SA 1 to HB 399** (committee substitute) — [source](http://legis.delaware.gov/json/BillDetail/GeneratePdfDocument?legislationId=129886&legislationTypeId=5&docTypeId=2)
+
+## Votes
+
+- SM — **41–0** (pass) · lower
+- SM — **39–0** (pass) · lower
+- SM — **21–0** (pass) · upper
+
+## Sponsors
+
+- Andria L. Bennett — primary (person)
+- Kendra Johnson — primary (person)
+- Marie Pinkney — primary (person)
+- Edward S. Osienski — cosponsor (person)
+- Eric Morrison — cosponsor (person)
+- Kimberly Williams — cosponsor (person)
+- Paul S. Baumbach — cosponsor (person)
+- Sherry Dorsey Walker — cosponsor (person)
+- Spiros Mantzavinos — cosponsor (person)
+
+## Timeline
+
+The legislative action history — every referral, reading, and vote.
+
+- **2022-05-03** Introduced and Assigned to Health & Human Development Committee in House `introduction, referral-committee`
+- **2022-05-11** Reported Out of Committee (Health & Human Development) in House with 1 Favorable, 7 On Its Merits `committee-passage, committee-passage-favorable`
+- **2022-05-17** Amendment HA 1 to HB 399 - Introduced and Placed With Bill `amendment-introduction`
+- **2022-05-19** Amendment HA 2 to HB 399 - Introduced and Placed With Bill `amendment-introduction`
+- **2022-05-19** Amendment HA 1 to HB 399 - Passed In House by Voice Vote `amendment-passage`
+- **2022-05-19** Amendment HA 2 to HB 399 - Passed In House by Voice Vote `amendment-passage`
+- **2022-05-19** Passed By House. Votes: 39 YES 2 ABSENT `passage`
+- **2022-05-19** Assigned to Health & Social Services Committee in Senate `introduction, referral-committee`
+- **2022-06-08** Reported Out of Committee (Health & Social Services) in Senate with 2 Favorable, 2 On Its Merits `committee-passage, committee-passage-favorable`
+- **2022-06-30** Amendment SA 1 to HB 399 - Introduced and Placed With Bill `amendment-introduction`
+- **2022-06-30** Amendment SA 1 to HB 399 - Passed By Senate. Votes: 21 YES `amendment-passage`
+- **2022-06-30** Laid On Table in Senate
+- **2022-07-01** Lifted From Table in Senate
+- **2022-07-01** Passed By Senate. Votes: 21 YES `passage`
+- **2022-07-01** Passed By House. Votes: 41 YES `passage`
+- **2022-10-03** Signed by Governor `executive-signature`
+
+## Source
+
+OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/614f4e60-ae0f-42de-9e2e-a9a0e61e4bd0`. Confidence: reported (aggregated from official Delaware legislature records).
+